from the archive · Modern era
Karl Landsteiner
June 14, 1868 – June 26, 1943 · physiologist · immunologist · physician · hematologist
By The Keeper · Published
AI-assisted writing, automatically checked. Editorial process
Karl Landsteiner was the Austrian-born physician and immunologist who discovered the human ABO blood groups in 1901, a finding that made safe blood transfusion possible and earned him the 1930 Nobel Prize in Physiology or Medicine. Working later at the Rockefeller Institute in New York, he co-discovered the Rh factor and helped identify the virus that causes polio. Anyone asking who was Karl Landsteiner is really asking how modern transfusion medicine began, since his classification of blood into distinct types remains the foundation of every blood bank in the world. He died in New York City in 1943, reportedly with a pipette still in hand, having worked in the laboratory until his final days.
Early Life
Karl Landsteiner was born on June 14, 1868, in Baden bei Wien, a spa town south of Vienna, into a Jewish family of some prominence. His father, Leopold Landsteiner, was a well-known journalist, newspaper editor, and doctor of law who died when Karl was only six years old [1]. The loss bound the boy closely to his mother, Fanny Hess Landsteiner, a devotion that lasted his whole life; after her death in 1908 he kept her death mask on the wall of his home [2].
The Vienna of Landsteiner's youth was the intellectual capital of the Habsburg empire, and its university had one of the strongest medical faculties in Europe. He enrolled in medicine at the University of Vienna in 1885, at age seventeen, and received his doctorate in 1891 [1]. Even as a student he was drawn less to the bedside than to the bench. A paper he published while still studying, on the influence of diet on the composition of blood, hinted at the direction his career would take [2].
In 1890 Landsteiner and his mother converted from Judaism to Roman Catholicism, a step taken by many assimilated Viennese Jews of the era. The conversion did not shield him from the antisemitism of Austrian society, and questions of origin and identity would follow him even into his American years [3].
Path to Prominence
After qualifying as a physician, Landsteiner made an unusual decision for a medical graduate: he spent five years, from 1891 to 1896, training in chemistry rather than clinical medicine. He worked in the laboratories of some of the most distinguished chemists of the age, including Emil Fischer in Würzburg, Eugen Bamberger in Munich, and Arthur Hantzsch in Zurich [1]. Fischer would later win the Nobel Prize in Chemistry, and the rigorous chemical grounding Landsteiner absorbed in those years shaped everything he did afterward. He came to see immunology as a chemical problem, at a time when most of his contemporaries treated it as a purely biological one.
Returning to Vienna in 1896, he became an assistant to Max von Gruber at the Hygiene Institute, where he studied the mechanism of immunity and the nature of antibodies [2]. From 1898 to 1908 he worked in the University of Vienna's department of pathological anatomy under Anton Weichselbaum, the bacteriologist who had identified the cause of epidemic meningitis. During this decade Landsteiner performed thousands of autopsies and published prolifically on morbid anatomy, serology, and bacteriology [1].
The work was punishing and the recognition slow. Vienna offered him neither a professorship nor adequate resources for years, yet the period between 1898 and 1908 produced the discovery for which the world remembers him. In 1908 he was finally appointed prosector at the Wilhelminen Hospital in Vienna, and in 1911 the university granted him the title of professor of pathological anatomy, though without the salary that normally accompanied the rank [2].
Major Achievements
Any account of Karl Landsteiner achievements begins with a short paper of 1901. Physicians had long observed that transfusing blood from one person to another sometimes saved a life and sometimes killed the patient outright, and nobody knew why. In 1900 Landsteiner noted in a footnote that the serum of one human being could clump, or agglutinate, the red blood cells of another. The following year he showed systematically that human blood falls into distinct groups, which he called A, B, and C (the last was later renamed O). His colleagues Alfred von Decastello and Adriano Sturli identified the rarer fourth group, AB, in 1902 [1]. The ABO blood group system explained the old transfusion disasters at a stroke: mixing incompatible types triggers agglutination and destruction of red cells inside the recipient's vessels [4].
The practical consequences unfolded over the following decades. Reuben Ottenberg in New York performed the first transfusions guided by blood typing in 1907, and cross-matching became routine during and after the First World War, when the demand for transfusion was enormous [4]. Landsteiner also pointed out in 1901 that blood group testing could resolve questions of identity, an insight that grew into forensic serology and, through the work of others, into the use of blood groups in paternity disputes. For the discovery of the human blood groups he received the Nobel Prize in Physiology or Medicine in 1930, nearly three decades after the original paper [5].
Blood groups were far from his only contribution. In 1906 Landsteiner and Viktor Mucha adapted dark-field microscopy to visualize the spirochete that causes syphilis, improving diagnosis of the disease [2]. In 1908 and 1909, with Erwin Popper, he transmitted poliomyelitis to monkeys by injecting them with material from the spinal cord of a child who had died of the disease, demonstrating that polio is caused by a filterable virus. That experiment opened the path that led, four decades later, to the polio vaccines [1].
His chemical training bore further fruit in the concept of haptens: small molecules that cannot provoke an immune response on their own but do so when attached to a larger carrier protein. Through painstaking experiments with artificially modified antigens, Landsteiner showed that antibody specificity depends on precise chemical structure. He gathered this work in his monograph The Specificity of Serological Reactions, first published in German in 1933, a book that helped turn immunology into a quantitative chemical science [6]. Finally, in 1940, working with Alexander Wiener, he described the Rh factor, the blood antigen whose incompatibility between mother and fetus causes hemolytic disease of the newborn. Recognition of the Rh system made transfusion safer still and eventually allowed physicians to prevent Rh disease in infants [7].
Personal Life
Landsteiner married Leopoldine Helene Wlasto, a member of Vienna's Greek Orthodox community, in 1916; she converted to her husband's Catholic faith. Their only child, Ernst Karl, was born the following year and later became a physician himself [2]. The family was close but private, and Landsteiner guarded that privacy fiercely throughout his life.
Colleagues described a man of austere habits and relentless standards. He worked long hours, expected precision from everyone around him, and had little patience for publicity or ceremony. Music was his chief recreation; he was an accomplished pianist, a common accomplishment in cultivated Viennese households of his generation [3]. He read widely in philosophy and retained a lifelong skepticism about conclusions that outran the evidence, a temperament visible in the caution of his scientific writing.
His sensitivity about identity produced one widely reported episode. In 1937, after being listed in a compilation of prominent Jews, Landsteiner sought legal means to keep his Jewish ancestry out of print, arguing that the publicity could harm his son. The request was declined, and the affair illustrated the anxieties of a converted Austrian Jew watching the rise of Nazism from across the Atlantic [3].
Later Years
The collapse of Austria-Hungary in 1918 left Vienna impoverished, its laboratories short of coal, equipment, and even laboratory animals. Landsteiner, then fifty, concluded that serious research had become impossible there. In 1919 he accepted a post as prosector at a small Catholic hospital in The Hague, in the Netherlands, where he performed routine pathology work while continuing his experiments on a modest scale [2]. The Dutch interlude was a step down in status, but it kept his research alive at a moment when much of central European science had stalled.
Rescue came from New York. In 1922 Simon Flexner invited him to join the Rockefeller Institute for Medical Research, and Landsteiner spent the rest of his career there. The institute gave him what Vienna never had: stable funding, good facilities, and freedom to follow his own questions. He became a United States citizen in 1929 [1]. The following year the Nobel committee in Stockholm honored him for the blood group discovery, and in his Nobel lecture he surveyed both the science and its consequences for transfusion, forensics, and anthropology [5].
He formally retired in 1939 with the title of emeritus member, but retirement changed almost nothing. He kept his laboratory and his schedule, and the Rh factor work with Wiener, arguably his second most consequential discovery, came after his official retirement [7]. On June 24, 1943, Landsteiner suffered a heart attack while working at his laboratory bench, pipette in hand according to institute accounts. He died two days later, on June 26, 1943, at the hospital of the Rockefeller Institute in New York City. His wife, then gravely ill with cancer, died later the same year [2].
Legacy
The most direct measure of Landsteiner's legacy is counted in transfusions. Blood typing and cross-matching, both descending from his 1901 paper, are performed before millions of transfusions every year, and the ABO and Rh systems he identified or co-identified remain the two most important considerations in transfusion medicine [4]. Blood banking, organ transplantation matching, and the management of hemolytic disease of the newborn all rest on foundations he laid. For this reason he is often called the father of transfusion medicine, and June 14, his birthday, is observed internationally as World Blood Donor Day [8].
Within science his influence runs deeper than any single discovery. By insisting that immune specificity was a problem of chemical structure, Landsteiner helped create immunochemistry as a discipline. His hapten studies framed the questions that later generations answered with the tools of molecular biology, and The Specificity of Serological Reactions remained required reading for immunologists long after his death [6]. The polio transmission experiments of 1908 and 1909 established the viral cause of the disease and set the stage for the vaccine work of Salk and Sabin [1].
Honors followed him posthumously as well as in life. Austria portrayed him on the 1,000 schilling banknote issued in 1997, medical societies award prizes in his name, and a lunar crater and institutions on several continents carry it too [8]. Among the enduring Karl Landsteiner facts, one has a certain symmetry: a scientist who spent his life avoiding attention became, through the letters A, B, AB, and O stamped on donor cards everywhere, one of the most quietly ubiquitous figures in modern medicine. Any Karl Landsteiner biography ends where daily medical practice begins, in the routine safety of a procedure that was lethal guesswork before him.
Questions & Answers
- What is Karl Landsteiner famous for?
- Karl Landsteiner is famous for discovering the ABO human blood groups in 1901, which made blood transfusion safe and predictable. He also co-discovered the Rh factor in 1940 and helped prove that poliomyelitis is caused by a virus.
- When was Karl Landsteiner born?
- Karl Landsteiner was born on June 14, 1868, in Baden bei Wien, a town near Vienna in what was then Austria-Hungary. His birthday is now observed each year as World Blood Donor Day.
- When did Karl Landsteiner win the Nobel Prize?
- He received the Nobel Prize in Physiology or Medicine in 1930 for his discovery of the human blood groups. The award came almost thirty years after his original 1901 paper describing the A, B, and O types.
- How did Karl Landsteiner die?
- Landsteiner suffered a heart attack on June 24, 1943, while working at his laboratory bench at the Rockefeller Institute in New York. He died two days later, on June 26, 1943, at the age of 75.
- Did Karl Landsteiner discover the Rh factor?
- Yes, together with Alexander Wiener he described the Rh blood factor in 1940, after his formal retirement. The discovery explained hemolytic disease of the newborn and further improved the safety of blood transfusion.
- Where did Karl Landsteiner work?
- He spent most of his early career at the University of Vienna and Viennese hospitals, then worked as a prosector in The Hague from 1919. From 1922 until his death he was a member of the Rockefeller Institute for Medical Research in New York City.
References
Every record in this archive is kept against verifiable sources.
- [1]Karl Landsteiner: Biographical. The Nobel Prize, Nobel Prize Outreach, 1930. https://www.nobelprize.org/prizes/medicine/1930/landsteiner/biographical/Web
- [2]Michael Heidelberger. Karl Landsteiner 1868-1943: A Biographical Memoir. National Academy of Sciences, Biographical Memoirs, 1969. http://www.nasonline.org/publications/biographical-memoirs/memoir-pdfs/landsteiner-karl.pdfJournal
- [3]Paul Speiser and Ferdinand G. Smekal. Karl Landsteiner, the Melancholy Genius: His Time and His Colleagues, 1868-1943. Verlag Brüder Hollinek, Vienna, 1975. Book
- [4]Blood group | Definition, Types, & Rh Factor. Encyclopaedia Britannica. https://www.britannica.com/science/blood-groupWeb
- [5]The Nobel Prize in Physiology or Medicine 1930. The Nobel Prize, Nobel Prize Outreach, 1930. https://www.nobelprize.org/prizes/medicine/1930/summary/Web
- [6]Karl Landsteiner. The Specificity of Serological Reactions. Harvard University Press (revised English edition), 1945. Book
- [7]Karl Landsteiner and Alexander S. Wiener. An Agglutinable Factor in Human Blood Recognized by Immune Sera for Rhesus Blood. Proceedings of the Society for Experimental Biology and Medicine, 1940. Journal
- [8]Karl Landsteiner | Austrian immunologist. Encyclopaedia Britannica. https://www.britannica.com/biography/Karl-LandsteinerWeb
help the keeper
Spotted an error, or hold a source the archive lacks? Every record can be corrected. Submissions are reviewed against authentic references before any change is made.

entered into the archive
kept by The Keeper